Jasinski Lawrence J 4

What Happened

• Lawrence J. Jasinski, a director of Lemaitre Vascular, acquired 476 shares of LMAT common stock on February 26, 2026. The shares were issued at $0.00 upon settlement of a Performance Share Unit (PSU) award granted December 6, 2024. No cash was paid for these shares; they were compensation that vested after a performance condition was met.

Key Details

• Transaction date: 2026-02-26; Filing date: 2026-03-02 (timely filed within the Form 4 filing window).
• Primary entry: Award/Grant (code A) — 476 shares @ $0.00 acquired.
• Derivative entries (code M): 1 share acquired @ $0.00 and 1 share disposed @ $0.00; these relate to conversion/release of dividend-equivalent rights tied to the PSU.
• Footnotes: PSUs granted 12/06/2024 vested 1/3 on 2/26/2026 upon satisfaction of performance conditions; remaining shares vest in equal annual installments over the next two years. Dividend equivalent rights were released on a one-for-one basis and are economically equivalent to shares.
• Shares owned after the transaction: not stated in the provided excerpt of the filing.

Context

• This was an award settlement (compensation), not an open-market purchase or sale, so it reflects vested equity compensation rather than a direct trading vote by the insider.
• The PSU has continued vesting schedule for remaining shares (one-third vested now, remaining two installments on future anniversaries). Derivative/conversion entries reflect administrative releases related to that award.